BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company''s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
最新股票文章

日圓走勢預測:第三方價格目標
2025年截至目前,美元兌日圓(USD/JPY)匯率年內下跌約9.41%。2025年4月25日,日圓兌美元收於142.8790,創下自2024年9月以來的最強水平之一,較2024年7月的高點161.942下跌約11.77%。
11:17, 19 6月 2025

黃金價格走勢分析2025:第三方目標與市場預測
黃金一直被視為經濟不確定時期的重要避險資產。隨著2025年受中央銀行政策轉向、通脹壓力變化以及地緣政治緊張局勢的影響,黃金在交易圈中仍然備受關注。
21:45, 28 4月 2025